Search

Your search keyword '"Glancy, Megan"' showing total 11 results
Start Over Author "Glancy, Megan"
11 results on '"Glancy, Megan"'

4. Effects of COVID-19 Pandemic Response on Service Provision for Sexually Transmitted Infections, HIV, and Viral Hepatitis, England

Author

Mitchell, Holly D., Vilaplana, Tatiana Garcia, Mandal, Sema, Ratna, Natasha, Glancy, Megan, Shah, Ammi, Simmons, Ruth, Penman, Celia, Kirsebom, Freja, Costella, Annastella, Brown, Alison E., Mohammed, Hamish, Delpech, Valerie, Sinka, Katy, and Hughes, Gwenda

Subjects
Epidemics -- Social aspects -- Control -- England, Sexually transmitted diseases -- Diagnosis -- Care and treatment, Hepatitis, Viral -- Diagnosis -- Care and treatment, Public health -- Management, Company business management, Health
Abstract

Beginning March 23, 2020, the UK government introduced social and physical distancing (SPD) measures to reduce transmission of severe acute respiratory syndrome 2 (SARS-CoV-2), and health staff were redeployed to [...]

Published
2022
Full Text
View/download PDF

5. Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study

Author

Trayner, Kirsten M.A., McAuley, Andrew, Palmateer, Norah E., Yeung, Alan, Goldberg, David J., Glancy, Megan, Hunter, Carole, Ritchie, Trina, Craik, Julie, Raeburn, Fiona, McTaggart, Stuart, Barnsdale, Lee, Campbell, John, Shepherd, Samantha J., Bradley-Stewart, Amanda, Gunson, Rory N., Templeton, Kate, and Hutchinson, Sharon J.

Published
2022
Full Text
View/download PDF

6. Prevalence of opioid dependence in Scotland 2015–2020: A multi‐parameter estimation of prevalence (MPEP) study

Author

Markoulidakis, Andreas, primary, Hickman, Matthew, additional, McAuley, Andrew, additional, Barnsdale, Lee R., additional, Welton, Nicky J., additional, Glancy, Megan, additional, Shivaji, Tara, additional, Collins, Craig, additional, Lang, Jaroslaw, additional, de Wit, Femke, additional, Hunt, Gordon, additional, Wilkinson, Levin, additional, Fraser, Rosalyn, additional, Yeung, Alan, additional, Horsburgh, Kirsten, additional, Priyadarshi, Saket, additional, Hutchinson, Sharon J., additional, and Jones, Hayley E., additional

Published
2024
Full Text
View/download PDF

8. Risk of drug-related mortality associated with prescribed and illicit benzodiazepine use among people receiving opioid-agonist treatment in Scotland

Author

Yeung, Alan, Palmateer, Norah, Saket Priyadarshi, Hickman, Matthew, Bishop, Jennifer, Glancy, Megan, Barnsdale, Lee, McAuley, Andrew, Hutchinson, Sharon, and Macleod, John

Subjects
Epidemiology, Medicine and Health Sciences, Public Health
Abstract

Background: Opioid-agonist treatment (OAT) is associated with reduced mortality risk among individuals with opioid dependence compared to those not receiving treatment (Santo Jr. et al., 2021). Use of benzodiazepines (prescribed and non-prescribed) is highly prevalent among people with opioid dependence (Jones et al, 2012). In Scotland, the number of drug-related deaths in which non-prescribed, illicitly produced benzodiazepines are implicated has risen markedly in recent years (National Records Scotland, 2022; McAuley, Matheson & Roberston, 2022). In 2021, these so-called ‘street benzos’ accounted for the majority of drug deaths involving benzodiazepines and are thought to be a driver of Scotland’s ongoing drug deaths epidemic (McAuley, Matheson & Roberston, 2022). Previous research in the UK has shown an association between co-prescribing of benzodiazepines with OAT and increased drug-related mortality risk (McCowan et al., 2009; Macleod et al, 2019). Other sedative/anxiolytic drugs commonly prescribed to OAT clients, such as gabapentinoids and z-drugs, may also have a role in polydrug and mortality trends (Abrahamsson et al., 2017). One descriptive study showed that gabapentinoid prescribing, and co-prescribing with opioids, in Scotland had risen markedly between 2006 and 2016, coinciding with a small increase in reports of their implication in drug-related deaths (Torrance et al., 2020). However, there was no strong evidence of an association between gabapentinoid co-prescription and drug-related mortality in a recent UK primary care study (Macleod et al., 2019). Aims: The aim of this study is to use linked data to quantify the risk of drug-related mortality associated with co-prescribing of benzodiazepines, gabapentinoids and z-drugs with OAT among recipients in Scotland (replicating findings from the rest of the UK; Macleod et al., 2019). We will further explore the impact of self-reported use of illicit benzodiazepines on drug-related mortality risk among this cohort, and how this has changed over time.

Published
2023
Full Text
View/download PDF

10. Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study.

Author

Fraser, Rosalyn, Yeung, Alan, Glancy, Megan, Hickman, Matthew, Jones, Hayley E., Priyadarshi, Saket, Horsburgh, Kirsten, Hutchinson, Sharon J., and McAuley, Andrew

Subjects
*SUICIDE statistics, *SUICIDE risk factors, *DEATH rate, *SUICIDE, *COHORT analysis
Abstract

Background and aims Design Setting Participants Measurements Findings Conclusion Opioid dependence is associated with an increased risk of suicide. Drug‐related mortality among people with opioid dependence in Scotland has more than tripled since 2010; less is known about changes in suicide risk. We aimed to determine if opioid agonist therapy (OAT) in Scotland is protective against suicide and to measure trends in suicide rates in those with opioid dependence over time.Retrospective cohort study.Scotland, UK.46 453 individuals in Scotland who received at least one prescription for OAT between 2011 and 2020 with over 304 000 person‐years (pys) of follow‐up.We calculated standardised mortality ratios (SMR) using the age‐ and sex‐specific suicide rates in Scotland for years 2011–2020. We fitted multivariable competing‐risk regression models to estimate suicide rates by OAT exposure and to estimate trends over time, adjusting for potential confounders.There were 575 deaths classed as suicide among the cohort and the overall suicide rate was 1.89 (95% confidence interval [CI] = 1.74–2.05) per 1000 pys. Age and sex SMR for suicide was 7.05 times (95% CI = 6.50–7.65) higher than in the general population. After adjustment, OAT was shown to be highly protective against suicide, with rates more than three times greater (adjusted hazard ratio: 3.07; 95% CI = 2.60–3.62) off OAT compared with on OAT. Suicide rates decreased over time, falling from 2.57 (95% CI = 2.19–3.02) per 1000 pys in 2011–12 to 1.48 (95% CI = 1.21–1.82) in 2019–20.People with opioid dependence in Scotland appear to have a greater risk of suicide than the general population. Treatment is protective, with rates of suicide lower among those on opioid agonist therapy. Suicide rates have decreased over time, during a period in which drug‐related death rates in Scotland have risen to globally high levels. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results